BIOFLOW III Asia Registry Orsiro Stent System
NCT01941290 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 387
Last updated 2017-09-28
Summary
Cliflical evaluation of th' Orsiro LESS 10 diabetic subjects requiring coronary revasculariza t ion with Drug Eluting Stefl ts (DES) .880 subjects will be enrolled in this registry. The sample subjects size may be increased in order to reach the subgroup sizes (Small Vessel and AMI).
Conditions
- Coronary Artery Disease
- Myocardial Ischemia
- Diabetes Mellitus Type 1 or 2
Sponsors & Collaborators
-
BIOTRONIK Asia Pacific Pte Ltd
lead INDUSTRY
Principal Investigators
-
Upendra Kaul, Dr · Fortis Escorts Heart Institute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2017-04-30
- Completion
- 2017-04-30
Countries
- China
- India
- Malaysia
- Sri Lanka
- Vietnam
Study Locations
More Related Trials
-
BIOFLOW-III Israel Satellite Registry
NCT01895712 ·Status: COMPLETED
-
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT06779630 ·Status: RECRUITING ·Phase: NA
-
BIOFLOW-III Austria Satellite Registry
NCT01667016 ·Status: COMPLETED
-
Study of the Orsiro Drug Eluting Stent System
NCT01356888 ·Status: UNKNOWN ·Phase: NA
-
Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent
NCT01939249 ·Status: UNKNOWN ·Phase: NA
-
BIOFLOW-III Canada Satellite Registry
NCT01880242 ·Status: COMPLETED
-
BIOFLOW-SV All Comers Registry
NCT03600948 ·Status: TERMINATED
-
BIOFLOW-III Romania Satellite Registry
NCT01593059 ·Status: TERMINATED
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT02389946 ·Status: COMPLETED ·Phase: NA
-
BIOTRONIK Orsiro Pre-Marketing Registration
NCT02870985 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT04175626 ·Status: COMPLETED
-
BIOFLOW-SV Portugal Registry
NCT03600961 ·Status: TERMINATED
-
Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis.
NCT01651390 ·Status: COMPLETED ·Phase: NA
-
Vascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation Lesions
NCT05200637 ·Status: UNKNOWN ·Phase: NA
-
BIOFLOW-china Post-marketing Study (BIOTRONIK)
NCT05667285 ·Status: TERMINATED
-
To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System
NCT07098195 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Orsiro™ Drug Eluting Stent in Routine Clinical Practice
NCT02039739 ·Status: COMPLETED
-
Randomized Trial Comparing Two Sirolimus-Eluting Stents in Diabetes Mellitus
NCT04660240 ·Status: RECRUITING ·Phase: NA
-
China Endeavor Registry: A Registry With The Endeavor Zotarolimus Eluting Coronary Stent in China
NCT00793312 ·Status: COMPLETED
-
Comparison of Biodegradable Stents: Orsiro and BioMatrix
NCT02084901 ·Status: COMPLETED ·Phase: PHASE4
-
Asian Registry of the BioFreedom Stent for STEMI Patients
NCT03609346 ·Status: COMPLETED
-
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents
NCT02508714 ·Status: UNKNOWN ·Phase: NA
-
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
NCT02419521 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions
NCT00489164 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Comparison of Biomatrix and Orsiro Drug Eluting Stent
NCT02299011 ·Status: COMPLETED ·Phase: PHASE4